These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20089949)

  • 1. HDL structure, function, therapeutics, and imaging.
    Hazen S
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):138. PubMed ID: 20089949
    [No Abstract]   [Full Text] [Related]  

  • 2. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
    Kontush A; Chapman MJ
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):144-53. PubMed ID: 16505860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].
    Båvenholm P; Attvall S; Nilsson PM
    Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2462-6. PubMed ID: 17002161
    [No Abstract]   [Full Text] [Related]  

  • 5. Dyslipidemia and cardiovascular diseases.
    Mahdavi H; Kim JB; Safarpour S; Tien DA; Navab M
    Curr Opin Lipidol; 2009 Apr; 20(2):157-8. PubMed ID: 19276898
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of lipid-lowering drug therapy in children and adolescents.
    Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA
    Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.
    Cardiovasc J Afr; 2009; 20(1):73-4. PubMed ID: 19287821
    [No Abstract]   [Full Text] [Related]  

  • 8. High-density lipoprotein cholesterol: current perspective for clinicians.
    Whayne TF
    Angiology; 2009; 60(5):644-9. PubMed ID: 19240106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The editor's roundtable: expanded versus standard lipid panels in assessing and managing cardiovascular risk.
    Sulkes D; Brown BG; Krauss RM; Segrest JP; Sniderman AD; Roberts WC
    Am J Cardiol; 2008 Mar; 101(6):828-42. PubMed ID: 18328849
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid screening and cardiovascular health in childhood.
    Daniels SR; Greer FR;
    Pediatrics; 2008 Jul; 122(1):198-208. PubMed ID: 18596007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitherapy for diabetes.
    Vos E
    CMAJ; 2006 Nov; 175(10):1246-7; author reply 1247. PubMed ID: 17098957
    [No Abstract]   [Full Text] [Related]  

  • 12. Demystifying good high-density lipoprotein from dysfunctional high-density lipoprotein.
    Drown DJ
    Prog Cardiovasc Nurs; 2008; 23(4):198-9. PubMed ID: 19067988
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of pharmacologic agents for treatment of diabetes mellitus, dyslipidemia, and hypertension in children and adolescents.
    Daniels SR
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):389-91. PubMed ID: 19349572
    [No Abstract]   [Full Text] [Related]  

  • 14. [Risk functions and the primary prevention of cardiovascular disease].
    Grau M; Marrugat J
    Rev Esp Cardiol; 2008 Apr; 61(4):404-16. PubMed ID: 18405521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics of apolipoproteins and associated proteins from plasma high-density lipoproteins.
    Davidsson P; Hulthe J; Fagerberg B; Camejo G
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):156-63. PubMed ID: 19778948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the road to better dyslipidemia outcomes.
    Hughes S
    Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of dyslipidaemia - evidence and practical recommendations.
    Nestel PJ; O'Brien R; Nelson M
    Aust Fam Physician; 2008 Jul; 37(7):521-7. PubMed ID: 18592069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
    Jones PH
    Am J Cardiol; 2007 Feb; 99(4A):133B-140B. PubMed ID: 17307065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate: treatment of hyperlipidemia and beyond.
    Rosenson RS
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1319-30. PubMed ID: 19018684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of HDL mimetics.
    Navab M; Shechter I; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):164-8. PubMed ID: 19608977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.